Abstract:Abstract Introduction Brain natriuretic peptide (BNP) is a well-established marker for heart failure in the general population however limited data are available on the value of BNP as a diagnostic and prognostic marker in adults with congenital heart disease (ACHD). The purpose of our study is to evaluate the relation between BNP levels and biventricular systolic and diastolic function in patients with ACHD. Methods We evaluated clinically stable ACHD patients who underwent echocardiography from May 2015 until January 2018. We studied the correlation of BNP with the degree of systolic and diastolic dysfunction of the left ventricle. Moreover we also investigate the relation of BNP with the right tricuspid annular plane systolic excursion (TAPSE), the fractional area change (FAC) and the pulmonary arterial systolic pressure (PASP). Results In total, 385 patients were included in our study (median age, 43 ±12 years; 61% male). Of the 385 patients, 193 (50%) had tetralogy of Fallot, 94 (24%) had systemic RV, including patients with transposition of the great arteries (TGA) after atrial switch operation (Mustard or Senning) and congenitally corrected TGA -ccTGA , 43 (11%) had univentricular hearts and Fontan physiology, 55 (14%) had other lesions. BNP levels were 66 ± 26 pg/mL and 93, ±31pg/mL, for patients with EF > 50% and 50%> EF >35% respectively (p = 0.003). BNP levels correlate with parameters reflecting LV filling pressure, including transmitral early diastolic velocity (E) 81 ± 29pg/mL and its ratio to early diastolic annular myocardial tissue velocity (E/Ea) 77 ± 17pg/mL. (r=-0.607, p = 0.003 r=-0.598, p = 0.005, respectively) BNP levels were also significantly higher in patients with impaired tricuspid annular plane systolic excursion 87 ± 21 pg/mL (TAPSE < 14mm; p = 0.002) and decreased RV FAC 81 ± 18 pg/mL (FAC <35% P= 0.004) and in patients with PASP≥35 mmHg (p = 0.003). The ROC curve and logistic regression analysis spotted the role of BNP in identifying systolic and diastolic dysfunction patterns in ACHD patients. Conclusion: In clinical stable ACHD patiens BNP levels correlate well with LV systolic dysfunction as well as with impaired diastolic function. Furthermore patients with impaired RV function and increased PASP have raised BNP levels. Therefore monitoring BNP levels plays an important role in management of clinical stable ACHD patients

The correlations between LVEDP and noninvasive indicators of heart failure in patients with coronary heart dis-ease with normal ejection fraction

Corelation Between Plasma N-terminal ProBNP(NT-proBNP) and Cardiac Dysfunction

Semi-quantitative assessment of left ventricular end-diastolic pressure with t ransthoracic ultrasound

Comparative Analysis Between Cardiopulmonary Exercise Testing and Echocardiography in Patients of Heart Failure with Normal Ejection Fraction

Correlation between Plasma Level of BNP and Left Ventricular Hypertrophy in Hypertension Patients

Is NT-proBNP an predictor for asymptomatic ventricular diastolic dysfunction in patients with coronary artery disease and preserved ejection fraction

Comparison of heart function parameters and correlation between plasma brain natriuretic peptide levels in non valvular disease patients with atrial fibrillation

Prognostic Value of Heart Failure Echocardiography Index in HF Patients with Preserved, Mid-Ranged and Reduced Ejection Fraction

The role of amino-terminal pro-B-type natriuretic peptide for evaluating the risk stratification in patients with chronic heart failure and low left ventricular ejection fraction

Evaluation of Left Ventricular Systolic Function Using Synchronized Analysis of Heart Sounds and the Electrocardiogram

The Relationship of Left Ventricular Function and Plasma Concentration of BNP and NT‐proBNP in Patients with Asymptomatic Diastolic Dysfunction and Diastolic Heart Failure

The diagnostic value of plasma BNP in the senile patients with normal eject fraction heart failure

A retrospective study on the clinical significance of cardiac computed tomography in heart failure patients with preserved ejection fraction

Left atrial ejection force as a marker for the diagnosis of heart failure with preserved ejection fraction

The Diagnostic Value of Plasma NPS in Patients of Type 2 Diabetes Mellitus with Diastolic Heart Failure

Correlation Between Brain Natriuretic Peptide Levels and the Prognosis of Patients with Left Ventricular Diastolic Dysfunction.

P1446 Correlation of B-Type Natriuretic Peptide with LV and RV Function Assessed by Echocardiography in Adults Congenital Heart Diseases Patients

Correlation between ratio of mitral peak velocity of early filling to early diastolic mitral annular velocity and brain natriuretic peptide in patients with diastolic heart failure

Plasma Brain Natriuretic Peptide Levels in the Diagnosis of Heart Failure

The Value of Neutrophil-to-Lymphocyte Ratio and Epicardial Adipose Tissue Thickness in Heart Failure With Preserved Ejection Fraction

The Effectiveness of NT-proBNP in Diagnosing Heart Failure